DOCSLIB.ORG

2009 NATIONAL REPORT (2008 Data) Latvia

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2009 NATIONAL REPORT (2008 Data) Latvia 2013 NATIONAL REPORT (2012 data) TO THE EMCDDA by the Reitox National Focal Point „LATVIA’’ New developments, trends and in- depth information on selected issues Reitox 2013 FOREWORD 2013 National Report, new developments, trends and in–depth information on selected issues is one of the national annual reports compiled by the National Focal Points in the European Information Network on Drugs and Drug Addiction (REITOX) which is co-ordinated by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The national reports form the basis for the EMCDDA’s annual report The state of the drugs problem in Europe. The national reports are compiled in accordance with the guidelines provided by the EMCDDA. The Latvian National Report discusses recent developments and research data from 2012 and early 2013. The sections that describe the drug situation during the past year (drug experimentation, problem drug use, health and social correlates and consequences, availability and supply of drugs) are linked with discussion on related societal interventions (prevention, treatment, harm reduction, social reintegration and control). Each section begins with background information on the subject and the latest data is discussed in the subsections. The length of the sections in the report depends on the amount of data available on each subject area. Head of Addiction Monitoring Division Aija Pelne (Centre for Disease Prevention and Control of Latvia) wrote Section 3 and Subsections 5.1. and 5.2. Anda Karnite (Riga Stradins University) wrote Subsection 6.1 and 7.2. Agnese Zīle- Veisberga (Ministry of the Interior of Republic of Latvia) wrote Section 9 and 10. We thank them warmly. The report was compiled and the remaining sections written by Ieva Pūgule, Mārcis Trapencieris, Linda Sīle and Ildze Redoviča at the Latvian Reitox National Focal Point, which operates at the Centre for Disease Prevention and Control of Latvia. Research data and comments from experts on different areas of the drug issue were used in drafting the report. We thank all the experts for their contribution and comments. The report has been approved by the deputy director of Centre for Disease Prevention and Control of Latvia/ EMCDDA Management Board member Dr. Dzintars Mozgis and the director of Centre Mrs. Inga Šmate. Riga, November 2013 Centre for Disease Prevention and Control of Latvia* 22 Duntes Street, Riga LV-1005, Latvia Tel.: +371 67043700 Fax.: +371 67043701 e-mail: [email protected] www.spkc.gov.lv *Centre for Disease Prevention and Control of Latvia was established on 1 April 2012. Centre is supervised by Ministry of Health and is aimed at strengthening Latvia’s public health system, preventing diseases, including infectious and rare diseases. 2 This report was written by: Ieva Pūgule Head of Latvian NFP, Centre for Disease Prevention and Control of Latvia Ildze Redoviča Researcher, Centre for Centre for Disease Prevention and Control of Latvia Linda Sīle Public Health Analyst, Centre for Disease Prevention and Control of Latvia Aija Pelne Head of Addiction Monitoring Division, Centre for Disease Prevention and Control of Latvia Agnese Zīle- Veisberga Ministry of the Interior of Republic of Latvia Anda Karnīte Department of Public Health and Epidemiology, Riga Stradins University Mārcis Trapencieris University of Latvia Philosophy and Sociology Institute We would specially like to thank the following: Astrīda Stirna Riga Psychiatry and Addiction Centre Jānis Bekmanis Ministry of the Interior of Republic of Latvia, National Drug coordinator Santa Pildava Centre for Disease Prevention and Control of Latvia Diāna Vanaga Centre for Disease Prevention and Control of Latvia Sniedze Karlsone Centre for Disease Prevention and Control of Latvia Agnese Freimane Centre for Disease Prevention and Control of Latvia Raina Ņikiforova Centre for Disease Prevention and Control of Latvia Inga Martinova Latvia State Centre for Forensic Medical Examination Inga Vovere The State Police Angelīna Gribova The State Police Please use the following citation: Centre for Disease Prevention and Control of Latvia (2013), 2013 National Report (2012 data) to the EMCDDA by the Reitox National Focal Point. Latvia: new developments, trends and in-depth information on selected issues. Riga: Centre for Disease Prevention and Control of Latvia 3 List of Abbreviations AIDS Acquired Immune Deficiency Syndrome ART Antiretroviral treatment BST Buprenorphine Substitution Treatment CA Court Administration CDPC Centre for Disease Prevention and Control of Latvia CHE The Centre of Health Economics CM Latvian Cabinet of Ministers CRPI Children's Rights Protection Inspectorate DHPP Department of Health Promotion and Prevention DRD Drug related deaths DRID Drug-related Infectious Diseases EC European Commission ECAD European Cities against Drugs EMCDDA European Monitoring Centre for Drugs and Drug Addiction ESPAD European school survey project on alcohol and other drugs EU European Union GMR General Mortality Register GPS General Population Survey HBV Hepatitis B virus HCV Hepatitis C virus HIV Human Immuno-deficiency Virus HSD Health Statistics Department IDU Injecting drug use ICD-10 International Classification of Diseases (10th revision) INCB International Narcotics Control Board LaSPAD National School Survey on Alcohol and other Drugs LNFP Latvian National Focal Point LPA Latvian Prison Administration LSCFME Latvian State Centre for Forensic Medical Examination MCA Monitoring Centre for Addiction MI Ministry of the Interior MMT Methadone maintenance therapy NAF National Armed Forces NFP National Focal Point NGO Non-Governmental Organisation PDU Problem Drug use PLHIV People living with HIV/AIDS PREDA Patient REgister DAta RPAC Riga Psychiatry and Addiction Centre SEA State Employment Agency SPS State Probation Service STD Sexually transmitted diseases STSDA Sexually Transmitted and Skin Diseases State Agency TDI Treatment Demand Indicator UNODC United Nations Office on Drugs and Crime WHO World Health Organization 4 Table of contents SUMMARY ......................................................................................................................................................... 6 PART A: NEW DEVELOPMENTS AND TRENDS .......................................................................................... 10 1. DRUG POLICY: LEGISLATION, STRATEGIES AND ECONOMIC ANALYSIS…………………………………………… 10 1.1. Legal framework………………………………………………………………………………………………………….. 10 1.2 National action plan, strategy, evaluation and coordination............................................................................. 12 2. DRUG USE IN THE GENERAL POPULATION AND SPECIFIC TARGETED GROUPS…………………………………… 14 2.1. Drug use in the general population……………………………………………………………………………………. 14 2.2. Drug Use in the school and youth population………………………………………………………………………… 20 3. PREVENTION………………………………………………………………………………………………………. 24 3.1. Environmental prevention……………………………………………………………………………………………….. 25 3.2. Universal prevention……………………………………………………………………………………………………...26 3.3. Selective prevention in at-risks groups and settings…………………………………………………………………. 32 3.4. Indicated prevention……………………………………………………………………………………………………… 33 3.5. National and local media campaigns.................................................................................................................34 4. PROBLEM DRUG USE………………………………………………………………………………………………36 4.1. Prevelence and incidence estimates of PDU………………………………………………………………………….. 36 4.2. Data on PDUs from non-treatment sources…………………………………………………………………………... 37 5. DRUG-RELATED TREATMENT: TREATMENT DEMAND AND TREATMENT AVAILABILITY…………………………….. 40 5.1. Strategy and policy……………………………………………………………………………………………………….. 40 5.2. Treatment systems………………………………………………………………………………………………………… 41 5.3. Access to treatment………………………………………………………………………………………………………..43 6. HEALTH CORRELATES AND CONSEQUENCES……………………………………………………………………... 60 6.1. Drug-related infectious diseases……………………………………………………………………………………….. 60 6.2. Other drug-related health correlates and consequences……………………………………………………………. 73 6.3. Drug related deaths and mortality of drug users…………………………………………………………………….. 74 7. RESPONSES TO HEALTH CORRELATES AND CONSEQUENCES……………………………………………………. 78 7.1. Prevention of drug related emergencies and reduction of drug-related deaths…………………………………. 78 7.2. Prevention and treatment of drug-related infectious diseases……………………………………………………… 78 8. SOCIAL CORRELATES AND SOCIAL REINTEGRATION……………………………………………………………… 81 8.1. Social exclusion and drug use………………………………………………………………………………………….. 81 8.2. Social reintegration……………………………………………………………………………………………………… 83 9. DRUG-RELATED CRIME, PREVENTION OF DRUG RELATED CRIME AND, PRISON………………………………….. 84 9.1. Drug- related crime………………………………………………………………………………………………………. 85 9.2. Drug law offences………………………………………………………………………………………………………… 86 9.3. Other drug- related crime……………………………………………………………………………………………….. 91 9.4. Prevention of drug- related crime……………………………………………………………………………………… 91 9.5. Interventions in the criminal justice system…………………………………………………………………………… 92 9.6. Drug use and problem drug use in prisons…………………………………………………………………………….93 9.7. Respnses to drug- related health issues in prisons…………………………………………………………………… 95 9.8. Reintegration of drug users after release form prison………………………………………………………………. 97 10. DRUG MARKETS…………………………………………………………………………………………………. 99 10.1. Availability and Supply..................................................................................................................................
Load more

Recommended publications
  • Bachelor Theses 1996 - 2020
    Bachelor Theses 1996 - 2020 ID Title Name Surname Year Supervisor Pages Notes Year 2020 Are individual stock prices more efficient than Jānis Beikmanis 2020 SSE Riga Student Research market-wide prices? Evidence on the evolution of 2020 Tālis Putniņš 49 01 Papers 2020 : 3 (225) Samuelson’s Dictum Pauls Sīlis 2020 Assessment of the Current Practices in the Justs Patmalnieks 2020 Viesturs Sosars 50 02 Magnetic Latvia Business Incubator Programs Kristaps Volks 2020 Banking business model development in Latvia Janis Cirulis 2020 Dmitrijs Kravceno 36 03 between 2014 and 2018 2020 Betting Markets and Market Efficiency: Evidence Laurynas Janusonis 2020 Tarass Buka 55 04 from Latvian Higher Football League Andrius Radiul 2020 Building a Roadmap for Candidate Experience in Jelizaveta Lebedeva 2020 Inga Gleizdane 53 05 the Recruitment Process Madara Osīte Company financial performance after receiving Ernests Pulks 2020 non-banking financing: Evidence from the Baltic 2020 Anete Pajuste 44 06 market Patriks Simsons Emīls Saulītis 2020 Consumer behavior change due to the emergence 2020 Aivars Timofejevs 41 07 of the free-floating car-sharing services in Riga Vitolds Škutāns 2020 Content Marketing in Latvian Tech Startups Dana Zueva 2020 Aivars Timofejevs 64 08 Corporate Social Responsibility: An Analysis of Laura Ramza 2020 Companies’ CSR Activities Relationship with Their 2020 Anete Pajuste 48 09 Financial Performance in the Baltic States Santa Usenko 2020 Determinants of default probabilities: Evidence Illia Hryzhenku 2020 Kārlis Vilerts 40 10 from
    [Show full text]
  • Latvia 2011 Country Report Global Youth Tobacco Survey (Gyts)
    LATVIA 2011 COUNTRY REPORT GLOBAL YOUTH TOBACCO SURVEY (GYTS) CONTENTS 1. Acknowledgements 3 2. Summary 4 3. Introduction 5 a. Country Demographics 5 b. WHO Framework Convention on Tobacco Control and MPOWER 5 c. Purpose and Rationale 6 d. Current State of Policy 8 e. Other Tobacco Surveys 8 f. Country-Specific Objectives 8 4. Methods 9 a. Sampling 9 b. Data Collection 9 c. Data Analysis 9 5. Results 10 a. Prevalence 10 b. Knowledge and Attitudes 11 c. Access and Availability 12 d. Exposure to Secondhand Smoke 13 e. Cessation 14 f. Media and Advertising 14 g. School Curriculum 15 6. Discussion 16 a. Summary of Results 16 b. Comparison to Previous Tobacco Surveys 17 c. Relevance to WHO FCTC/WHO MPOWER 18 d. Relevance to Country 19 e. Proposed Interventions/Further Studies 20 7. Recommendations 21 8. References 22 2 Acknowledgements Latvia acknowledges the support of the World Health Organization’s Europe Region, and the United States Centers for Disease Control and Prevention (CDC) for providing technical and financial support to develop and print this document. This report has been prepared by Iveta Pudule, Biruta Velika and Daiga Grinberga, Senior Public Health Analysts, Centre for Disease Prevention and Control of Latvia and is based on the 2011 Global Youth Tobacco Survey findings in LATVIA. 3 Summary In 1998, the World Health Organization (WHO), the US Centers for Disease Control and Prevention (CDC) and the Canadian Public Health Association (CPHA) began the development of the Global Tobacco Surveillance System (GTSS) with the Global Youth Tobacco Survey (GYTS). It is a school-based survey that is targeted towards youth aged 13-15 years old.
    [Show full text]
  • International Smoking Statistics
    International Smoking Statistics Web Edition A collection of worldwide historical data USSR and successor countries Barbara Forey, Jan Hamling, John Hamling, Alison Thornton, Peter Lee P N Lee Statistics & Computing Ltd 17 Cedar Road Sutton SM2 5DA, UK www.pnlee.co.uk This report is an updated version of Chapter 29 of International Smoking Statistics 2nd edition, Wolfson Institute of Preventive Medicine and OUP, 2002, www.oup.co.uk/isbn/0-19-850856-5 Date of issue: 5-Jul-2016 (First issue) © Barbara Forey, Jan Hamling, John Hamling, Alison Thornton, Peter Lee, 2016 This work is copyright. It may be reproduced or quoted in whole or in part for study or research purposes, subject to inclusion of an acknowledgement of the source. It may not be reproduced for purposes other than those above or sold without written permission from the authors. Issue History: First issued 5-Jul-2016 2 USSR and successors 5-Jul-2016 Contents Contents .................................................................................................................................. 3 List of Figures ...................................................................................................................... 4 Preface .................................................................................................................................... 5 Downloads ........................................................................................................................... 5 Acknowledgements .................................................................................................................
    [Show full text]
  • Report on the Contextual Determinants of Child Health Policy
    Report on the contextual determinants of child health policy 28 February 2017 Authors Kinga Zdunek, Peter Schröder-Bäck, Mitch Blair, Michael Rigby DRAFT Report on contextual determinants of child health policy in Europe Status Report on the contextual determinants of child health policy Third draft Origin Work Package 1: Identification of Models of Children’s Primary Health Care Task 7: National Health and Policy Culture Distribution All members of MOCHA via WP Leaders and website Context This report will provide MOCHA members with an overview on the contextual determinants of child health policy in Europe 2 DRAFT Report on contextual determinants of child health policy in Europe Contents 1. Introduction ....................................................................................................................... 6 1.1. Child-centric perspective ........................................................................................... 6 1.2. Aim of the study .......................................................................................................... 8 1.3. Theoretical background............................................................................................. 8 2. Methodology ......................................................................................................................10 3. Case studies of current child health issues in Europe ....................................................13 3.1. Anti-vaccination movement across Europe .............................................................13
    [Show full text]
  • Tupakkakertomus 2006 Kansanterveyslaitoksen Julkaisuja Oikeus Savuttomaan Elämään
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Julkari Marjaana Pennanen • Kristiina Patja Marjaana Pennanen • Kristiina Patja • Katja Joronen • Katja Joronen — Tupakka Tupakkakertomus 2006 ISBN 951-740-618-5 Oikeus savuttomaan elämään 9 7 8 9 5 1 7 4 0 6 1 8 5 ISBN 951-740-618-5 (print) ISBN 951-740-619-3 (pdf) ISSN 0359-3576 http://www.ktl.fi/portal/2920 Helsinki 2006 Kansanterveyslaitoksen julkaisuja B 3/2006 Edita Prima Oy kertomus 2006 Kansanterveyslaitoksen julkaisuja B 3/2006 Publications of the National Public Health Insitute Marjaana Pennanen • Kristiina Patja • Katja Joronen Tupakkakertomus 2006 Oikeus savuttomaan elämään Helsinki, 2006 1 Kiitämme Tupakkakertomuksen laatimisessa auttaneita henkilöitä: Terhi Aalto-Setälä, Kansanterveyslaitos Ari Haukkala, Helsingin yliopisto Hanne Heikkinen, Kansanterveyslaitos Satu Helakorpi, Kansanterveyslaitos Laura Kestilä, Kansanterveyslaitos Urpo Kiiskinen, Kansanterveyslaitos Kari Kuulasmaa, Kansanterveyslaitos Tiina Laatikainen, Kansanterveyslaitos Jukka Lindeman, Kansanterveyslaitos Meri Paavola, Kansanterveyslaitos Ritva Prättälä, Kansanterveyslaitos Anastasiya Rogacheva, Kansanterveyslaitos Patrick Sandström, Kansanterveyslaitos Hanna Tolonen, Kansanterveyslaitos Kerttu Tossavainen, Kuopion yliopisto Ellen Tuomaala, Kansanterveyslaitos Eeva Riitta Vartiainen, Kansanterveyslaitos Erkki Vartiainen, Kansanterveyslaitos Sari Yrjölä, Kansanterveyslaitos 2 SISÄLLYSLUETTELO TIIVISTELMÄ ................................................................................................................................
    [Show full text]
  • Global Prevalence of Tobacco Use in Adolescents and Its Adverse Oral Health Consequences
    Open Access Maced J Med Sci electronic publication ahead of print, published on October 11, 2019 as https://doi.org/10.3889/oamjms.2019.542 ID Design Press, Skopje, Republic of Macedonia Open Access Macedonian Journal of Medical Sciences. https://doi.org/10.3889/oamjms.2019.542 eISSN: 1857-9655 Review Article Global Prevalence of Tobacco Use in Adolescents and Its Adverse Oral Health Consequences Muhammad Ashraf Nazir1*, Asim Al-Ansari1, Nabeela Abbasi2, Khalid Almas1 1Department of Preventive Dental Sciences, College of Dentistry, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia; 2Department of Oral Biology, Rawal Institute of Health Sciences, Islamabad, Pakistan Abstract Citation: Ashraf Nazir MA, Al-Ansari A, Abbasi N, Almas BACKGROUND: Smoking is associated with various systemic conditions and contributes to a huge financial K. Global Prevalence of Tobacco Use in Adolescents and burden to economies around the world. Its Adverse Oral Health Consequences. Open Access Maced J Med Sci. https://doi.org/10.3889/oamjms.2019.542 AIM: The study aimed to evaluate global data about the prevalence of tobacco use among male and female Keywords: Tobacco use; Oral health conditions; adolescents and to discuss smoking-related oral complications. Adolescence; Global prevalence; Cigarette smoking *Correspondence: Muhammad Ashraf Nazir. Department METHODS: The prevalence data of tobacco use among adolescents (13-15 years) was retrieved from the World of Preventive Dental Sciences, College of Dentistry, Imam Health Organization (Global Health Observatory). The World Bank’s statistics about gross national income (GNI) Abdulrahman Bin Faisal University, Dammam, Saudi Arabia. E-mail: [email protected] per capita were used to categorise low-income, lower-middle-income, upper-middle-income, and high-income countries.
    [Show full text]
  • Issues Latvia
    Issues Latvia Tobacco harms the health, the treasury, and the spirit of Latvia. Every year, more than 4000 of its people are killed by tobacco-caused disease. Still, more than 2000 children (10-14 years old) and 536000 adults (15+ years old) continue to use tobacco each day. Complacency in the face of the tobacco epidemic insulates the tobacco industry in Latvia and ensures that tobacco's death toll will grow every year. Tobacco control advocates must reach out to other communities and resources to strengthen their efforts and create change. Adult Smoking (15+ Y.O.) Children Smoking (10-14 Y.O.) Deaths % using tobacco daily: 2015 % using tobacco daily: 2015 % caused by tobacco: 2016 Male Boys 48.9% 3.91% More men smoke in Latvia than on More boys smoke in Latvia than on average in very high-HDI countries. average in very high-HDI countries. Female Girls 24.3% 3.12% Male More women smoke in Latvia than on More girls smoke in Latvia than on average average in very high-HDI countries. in very high-HDI countries. 23.05% More men die in Latvia than on average in very high-HDI countries. Female 6.27% Even though fewer women die from tobacco in Latvia than on average in very high-HDI countries, tobacco still kills 18 women every week, necessitating action from policymakers. Societal Harms Smokeless Tobacco % using tobacco daily: 2013 The economic cost of smoking in Latvia amounts to 577 million euros. This includes direct costs related to n/a healthcare expenditures and indirect costs related to lost n/a productivity due to early mortality and morbidity.
    [Show full text]
  • RIVM Rapport 270051011 Dare to Compare! Benchmarking Dutch Health with the European Community Health Indicators (ECHI)
    Dare to Compare! Benchmarking Dutch health with the European Community Health Indicators (ECHI) How does public health in the Netherlands compare to public health in other European Union (EU) countries? Are we among the top five or lagging behind? Does the picture change when focusing on specific subjects? This report compares the Netherlands to EU countries along a set of more than eighty European health indicators on, for example, disease, lifestyle and prevention. This is the first time that the indicators that make up the so-called ECHI (European Community Health Indicator) shortlist are used for benchmarking Dutch public health. This shortlist has been adopted by the EU to assist health policy makers in identifying common challenges, priorities and opportunities, and to learn from other countries’ experiences. The systematic benchmark approach also provides a detailed view on the actual availability, comparability and quality of data sets, both within the Netherlands and throughout the EU. It becomes apparent that EU-funded projects and Eurostat activities increasingly contribute to better data quality and more valid comparisons, but much work is still to be done. Dare to Compare! Given the ambition of the Dutch Ministry of Health, Welfare and Sport to get the Netherlands back into the top five of the healthiest European countries, a benchmark is a good exercise to identify possibilities for improvement and issues that require policy attention. This report was commissioned by the Ministry of Health, Welfare and Sport. Harbers MM | Van der Wilk EA | Kramers PGN | Kuunders MMAP | Verschuuren M | Eliyahu H | Achterberg PW Dare to Compare! RIVM Benchmarking Dutch health with the National Institute for Public Health and the Environment European Community Health Indicators (ECHI) Centre for Public Health Forecasting PO Box 1 3720 BA Bilthoven The Netherlands www.rivm.nl/ With respect to the front cover: In English the idiom ‘comparing apples and oranges’ is commonly used to indicate that some items have not been validly compared.
    [Show full text]
  • The Baltic Sea Region the Baltic Sea Region
    TTHEHE BBALALTTICIC SSEAEA RREGIONEGION Cultures,Cultures, Politics,Politics, SocietiesSocieties EditorEditor WitoldWitold MaciejewskiMaciejewski A Baltic University Publication Use and abuse of tobacco, 45 alcohol and narcotics – a Baltic dilemma Sture Korpi, Lars Rydén, Vera Segraeus This chapter deals with public health questions in the Baltic Sea region. The first part presents health problems related to use of tobacco, alcohol and narcotics in the region. The second part deals with drugs and abuse patterns in the region, based on results from three research projects that have recently been completed. 1. Public health in the Baltic Sea region The social situation in the countries in the Baltic Sea region shows a very heterogeneous pic- ture. While the Nordic countries in the west have one of the highest life expectancies in the world, the former communist countries are rather on the lower end of this scale and among the worst in the industrial countries. These differences reflect a corresponding difference in public health in the countries, which in turn relates to, among other factors, differences in social situation, economies, health care, and social security systems. Here we will focus on the use and abuse of tobacco, alcohol and narcotics, and how this use and abuse relates to health, social conditions and economic development in the societies. All three are used as stimulantia, and create, more or less efficiently, a dependence among the users. Alcohol is by far the most relevant and will be discussed in some detail. Tobacco might be less destructive but is used by a very large share of the population and has therefore serious consequences for public health, while drugs, used by much fewer, are on the other hand very destructive.
    [Show full text]
  • L 333 Official Journal
    ISSN 1977-0677 Official Journal L 333 of the European Union Volume 56 English edition Legislation 12 December 2013 Contents II Non-legislative acts REGULATIONS ★ Commission Implementing Regulation (EU) No 1320/2013 of 3 December 2013 correcting Implementing Regulation (EU) No 385/2012 on the farm return to be used for determining the incomes of agricultural holdings and analysing the business operation of such holdings 1 ★ Commission Implementing Regulation (EU) No 1321/2013 of 10 December 2013 establishing the Union list of authorised smoke f lavouring primary products for use as such in or on foods and/or for the production of derived smoke f lavourings ( 1) . 54 ★ Commission Implementing Regulation (EU) No 1322/2013 of 11 December 2013 on the granting of unlimited duty-free access to the Union for 2014 to certain goods originating in Norway resulting from the processing of agricultural products covered by Council Regulation (EC) No 1216/2009 . 68 Commission Implementing Regulation (EU) No 1323/2013 of 11 December 2013 establishing the standard import values for determining the entry price of certain fruit and vegetables . 70 Commission Implementing Regulation (EU) No 1324/2013 of 11 December 2013 fixing an acceptance percentage for the issuing of export licences, rejecting export-licence applications and suspending the lodging of export-licence applications for out-of-quota sugar . 72 (Continued overleaf) Price: EUR 4 ( 1 ) Text with EEA relevance Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period. The titles of all other acts are printed in bold type and preceded by an asterisk.
    [Show full text]
  • RSU Akadēmiskā Personāla Publikācijas Un Promocijas Darbi”
    RĪGAS STRADIŅA UNIVERSITĀTES BIBLIOTĒKA RĪGAS STRADIŅA UNIVERSITĀTES AKADĒMISKĀ PERSONĀLA PUBLIKĀCIJAS UN PROMOCIJAS DARBI 2018. gadā RĪGA – RSU – 2019 RĪGAS STRADIŅA UNIVERSITĀTES BIBLIOTĒKA INFORMĀCIJAS, BIBLIOGRĀFIJAS UN INFORMĀCIJPRATĪBAS NODAĻA RĪGAS STRADIŅA UNIVERSITĀTES AKADĒMISKĀ PERSONĀLA PUBLIKĀCIJAS UN PROMOCIJAS DARBI 2018. gadā Bibliogrāfiskais rādītājs RĪGA – RSU – 2019 1 Sastādītājas: Anda Rundāne, Olga Suškova, Linda Rudzīte, Sandra Martina Par izdevumu atbild: Ināra Aploka, Signe Riekstiņa 2 SATURS PRIEKŠVĀRDS --------------------------------------------------------------------------------------- 4 Promocijas darbi --------------------------------------------------------------------------------------- 5 Grāmatas un brošūras --------------------------------------------------------------------------------- 6 Grāmatas daļas ---------------------------------------------------------------------------------- 10 Raksti -------------------------------------------------------------------------------------------- 20 Tēzes --------------------------------------------------------------------------------------------- 115 Intelektuālā īpašuma tiesību objekti --------------------------------------------------------- 263 Papildinājums iepriekšējo gadu publikācijām ---------------------------------------------- 264 RSU akadēmiskā personāla autoru alfabētiskais rādītājs --------------------------------- 267 3 PRIEKŠVĀRDS Bibliogrāfiskā rādītāja mērķis ir iezīmēt un apkopot RSU mācībspēku un zinātnisko darbinieku galvenos darba virzienus
    [Show full text]
  • Tupakkakertomus 2003
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Julkari Kansanterveyslaitoksen julkaisuja B 2 / 2004 Publications of the National Public Health Institute Kristiina Patja • Ari Haukkala Tupakkakertomus 2003 Helsinki, 2004 Kansanterveyslaitoksen julkaisuja B 2 / 2004 Publications of the National Public Health Institute Kristiina Patja • Ari Haukkala Tupakkakertomus 2003 Kansanterveyslaitos Epidemiologian ja terveyden edistämisen osasto KTL-National Public Health Institute, Finland Department of Epidemiology and Health Promotion Helsinki, 2004 Kansanterveyslaitoksen tupakkatyöryhmä Aulikki Nissinen, KTL, puheenjohtaja Varalla: Mervi Hara, Suomen Ash ry Riitta Muotka, Hengitysliitto Heli Kari Reijula, TTL Antero Heloma, TTL Liisa Katajamäki, STM Pirjo Koskinen-Ollonqvist, TEK Harri Vertio, TEK Matti Kunnari, STTV Leena Leikas, STTV Jouko Lönnqvist, KTL Kimmo Kuoppasalmi, KTL Matti Rautalahti, Suomen Syöpäyhdistys Satu Lipponen, Suomen Syöpäyhdistys Matti Rimpelä, Stakes Salme Ahlström, Stakes Antti Uutela, KTL Patrick Sandström, KTL Erkki Vartiainen, KTL Meri Paavola, KTL Copyright National Public Health Institute KTL Julkaisija - Utgivare - Publisher Kansanterveyslaitos (KTL) Mannerheimintie 166 00300 Helsinki Puh. vaihde (09) 47441, telefax (09) 4744 8338 Folkhälsoinstitutet Mannerheimvägen 166 00300 Helsingfors Tel. växel (09) 47441, telefax (09) 4744 8338 National Public Health Institute Mannerheimintie 166 00300 Helsinki Telephone + 358-9-47441, telefax +358-9-4744 8338 ISBN: 951-740-416-6 (PDF)
    [Show full text]